Prescient Therapeutics Limited (ASX:PTX)

Prescient Therapeutics Statistics

Total Valuation

ASX:PTX has a market cap or net worth of AUD 79.92 million. The enterprise value is 72.99 million.

Market Cap	79.92M
Enterprise Value	72.99M

Important Dates

The next estimated earnings date is Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:PTX has 1.05 billion shares outstanding.

Current Share Class	1.05B
Shares Outstanding	1.05B
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	9.50%
Owned by Institutions (%)	1.05%
Float	928.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	18.34
PB Ratio	7.02
P/TBV Ratio	8.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-9.97
EV / Sales	16.75
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.08

Current Ratio	4.08
Quick Ratio	3.75
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -49.72% and return on invested capital (ROIC) is -31.63%.

Return on Equity (ROE)	-49.72%
Return on Assets (ROA)	-26.95%
Return on Invested Capital (ROIC)	-31.63%
Return on Capital Employed (ROCE)	-66.10%
Weighted Average Cost of Capital (WACC)	5.29%
Revenue Per Employee	1.45M
Profits Per Employee	-2.44M
Employee Count	3
Asset Turnover	0.25
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +31.03% in the last 52 weeks. The beta is 0.19, so ASX:PTX's price volatility has been lower than the market average.

Beta (5Y)	0.19
52-Week Price Change	+31.03%
50-Day Moving Average	0.08
200-Day Moving Average	0.05
Relative Strength Index (RSI)	42.54
Average Volume (20 Days)	1,272,476

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:PTX had revenue of AUD 4.36 million and -7.32 million in losses. Loss per share was -0.01.

Revenue	4.36M
Gross Profit	4.36M
Operating Income	-7.54M
Pretax Income	-7.32M
Net Income	-7.32M
EBITDA	-7.54M
EBIT	-7.54M
Loss Per Share	-0.01

Balance Sheet

The company has 6.93 million in cash and n/a in debt, with a net cash position of 6.93 million or 0.01 per share.

Cash & Cash Equivalents	6.93M
Total Debt	n/a
Net Cash	6.93M
Net Cash Per Share	0.01
Equity (Book Value)	11.39M
Book Value Per Share	0.01
Working Capital	9.74M

Cash Flow

Operating Cash Flow	-7.24M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of -172.98% and -168.09%.

Gross Margin	100.00%
Operating Margin	-172.98%
Pretax Margin	-168.09%
Profit Margin	-168.09%
EBITDA Margin	-172.96%
EBIT Margin	-172.98%
FCF Margin	n/a

Dividends & Yields

ASX:PTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-9.16%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 2, 2014. It was a reverse split with a ratio of 0.05.

Last Split Date	Dec 2, 2014
Split Type	Reverse
Split Ratio	0.05

Scores

ASX:PTX has an Altman Z-Score of -1.87 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.87
Piotroski F-Score	2